Results 131 to 140 of about 63,206 (209)

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China. [PDF]

J Clin Transl Hepatol
Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Zhang L, Wu S, Tang H, Li J, Lin F, Yang Y, Gong G, Luo Y, Chen Y, Abramov F, Yee LJ, Wang H, Mateo R, Yazdi T, Botros I, Chen C, Huang Y, Zhang M, Jia J.   +23 more
europepmc   +1 more source

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply [PDF]

Clinical and Molecular Hepatology
Hyeyeon Hong, Jonggi Choi
doaj   +1 more source

Monitoring Adherence and Renal Safety of Nucleos(t)ide Analogs for Patients With Chronic Hepatitis B. [PDF]

Clin Transl Gastroenterol
Hsu CC, Chen ZE, Chao FH, Chou CY, Chang YL, Chou YC, Hou MC, Wu JC, Su CW.   +8 more
europepmc   +1 more source

Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. [PDF]

World J Hepatol
Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF.   +7 more
europepmc   +1 more source

(The Lancet)red: a missed opportunity. [PDF]

, 2006
Alexandra Calmy, Donnelly, Felipe Garcia de la Vega, Fernando Pascual, Gilks, Marseille, Nathan Ford, Sheila Shettle, Williams   +8 more
core   +2 more sources

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]

Front Med (Lausanne)
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc   +1 more source

The Role of Prior HBV Infection on the Efficacy of 3TC/DTG as a Maintenance Therapy. [PDF]

Viruses
Matucci T, Occhineri S, Palomba A, Vatteroni ML, Del Bono L, Polidori M, Iapoce R, Borghetti A, Falcone M.   +8 more
europepmc   +1 more source

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. [PDF]

PLoS One
Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Romero A, Vallecillos CG, Calleja MÁ, Hidalgo-Tenorio C.   +19 more
europepmc   +1 more source

Low Bone Mineral Density in Men Living with HIV on Tenofovir Antiretroviral Therapy: A Cross-Sectional Exploratory Study from a Malaysian Tertiary Hospital. [PDF]

Trop Med Infect Dis
Daud MR, Periyasamy P, Chin KY, Kori N, Zainulabid UA, Qian Yew S, Mohammad Kazmin NE, Khee Cheong X.   +7 more
europepmc   +1 more source